» Articles » PMID: 6092569

Preparation of Four Fluorine- 18-labeled Estrogens and Their Selective Uptakes in Target Tissues of Immature Rats

Overview
Journal J Nucl Med
Specialty Nuclear Medicine
Date 1984 Nov 1
PMID 6092569
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Four fluorine- 18-labeled estrogens--16 alpha-[18F]fluoro-estradiol-17 beta (1), 16 beta-[18F]fluoro-estradiol-17 beta (2), (2R, 3S)-1-[18F]fluoro-2,3-bis(4-hydroxyphenyl)-pentane (1-[18F]fluoropentestrol) (3), and (3R, 4S)-1-[18F]fluoro-3,4-bis(4-hydroxyphenyl)hexane (1-[18F]fluorohexestrol) (4)--have been prepared by simple displacement reactions utilizing reactive trifluoromethane sulfonate (triflate) precursors and F-18 fluoride ion. All four fluoroestrogens have high affinity for the estrogen receptor. In immature female rats, they are taken up by target tissues, such as the uterus, with very high selectivity: uterus-to-blood ratios at 1 hr are: Compound 1, 39; Compound 2, 12; Compound 3, 13; and Compound 4, 19. Average uterus-to-blood ratios exceed 80 for Compound 1 at 2 hr. That the uptake process involves an estrogen-specific binder of limited capacity is demonstrated by the suppressive effect of coadministered unlabeled estradiol on target tissue uptake.

Citing Articles

Radiosynthesis and Preclinical Evaluation of F-Labeled Estradiol Derivatives with Different Lipophilicity for PET Imaging of Breast Cancer.

Friedel A, Prante O, Maschauer S Cancers (Basel). 2024; 16(15).

PMID: 39123367 PMC: 11311842. DOI: 10.3390/cancers16152639.


Molecular Imaging of Steroid Receptors in Breast Cancer.

Keigley Q, Fowler A, OBrien S, Dehdashti F Cancer J. 2024; 30(3):142-152.

PMID: 38753748 PMC: 11101139. DOI: 10.1097/PPO.0000000000000715.


Synthesis of a [F]F Estradiol Derivative via Click Chemistry Using an Automated Synthesis Module: In Vitro Evaluation as Potential Radiopharmaceutical for Breast Cancer Imaging.

Tejeria M, Pereira M, Gambini J, Duarte P, Giglio J, Rey A Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543174 PMC: 10975010. DOI: 10.3390/ph17030388.


Targeting the Oxytocin Receptor for Breast Cancer Management: A Niche for Peptide Tracers.

Kalaba P, Sanchez de la Rosa C, Moller A, Alewood P, Muttenthaler M J Med Chem. 2024; 67(3):1625-1640.

PMID: 38235665 PMC: 10859963. DOI: 10.1021/acs.jmedchem.3c01089.


Androgen Receptor Imaging in the Management of Hormone-Dependent Cancers with Emphasis on Prostate Cancer.

Kairemo K, Hodolic M Int J Mol Sci. 2023; 24(9).

PMID: 37175938 PMC: 10179508. DOI: 10.3390/ijms24098235.